Idiopathic Pulmonary Fibrosis

Jeremy Feldman, MD

Knowledge is Power. Learn More & Breathe Better.

Idiopathic Pulmonary Fibrosis

Pulmonary Fibrosis MD is an educational resource for patients, caregivers, friends, and family members interested in learning about Idiopathic Pulmonary Fibrosis or IPF.

Idiopathic Pulmonary Fibrosis

It is an exciting time for the Pulmonary Fibrosis community because new treatments are currently being researched and approved. Pulmonologist Jeremy Feldman, MD has devoted his career to treating patients with advanced lung diseases such as IPF and has developed this educational resource to help educate the community and provide the most up to date information on living with and treating Idiopathic Pulmonary Fibrosis.

This site provides information on:

We strive to provide a comprehensive base of information about Pulmonary Fibrosis, as well as current and niche topics that we cover in the blog posts. Our aim is to provide a unique and real life perspective on the issues that IPF patients face. Topics may include traveling with IPF, exercise, pulmonary rehabilitation, oxygen tips, medications, transplant, conditions related to IPF, vaccination, and much more. We try to address the practical every day issues real patients and caregivers are struggling with. Search our blog posts and chances are we’ve written about it.

All information on this site is written & edited by an MD or RN  specializing in advanced lung diseases such as Idiopathic Pulmonary Fibrosis.

The Latest Articles

Interstitial Lung Disease and Progressive Pulmonary Fibrosis

By

Disorders characterized by inflammation or scarring in the lungs may be the most complicated area within lung medicine.  Not only are the names confusing but they have repeatedly changed over the past 50 years.  Furthermore, many of the early studies describing the natural history of one disease or another have turned out to be inaccurate.  To make matters […]

New Drugs Moving Forward for IPF

By

BI 1015550 The past few months have brought very exciting news for IPF patients.  A novel drug being developed by Boehringer Ingelheim (BI 1015550) showed positive results in a phase 2 study.  This new medication blocks the phosphodiesterase 4B receptor.  Blockade of this receptor has shown promise in animal models by causing reduced inflammation and […]

FAQs: Emphysema, Exercise & Lung Biopsy

By

Dr. Feldman addresses some common questions below. I have pulmonary fibrosis and emphysema.  Why am I so short of breath? Emphysema is often a smoking related lung disease.  The air sacs are destroyed and the lung tissue starts to look like Swiss cheese.  Pulmonary fibrosis replaces the normal lung tissue with scar formation, especially in the lower lobes.  In […]